These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24685209)

  • 1. [Immunologic mechanisms involved in rituximab failure during adult immune thrombocytopenia].
    Audia S; Saas P; Bonnotte B
    Med Sci (Paris); 2014 Mar; 30(3):239-42. PubMed ID: 24685209
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D
    Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients.
    Zwaginga JJ; van der Holt B; Te Boekhorst PA; Biemond BJ; Levin MD; van der Griend R; Brand A; Zweegman S; Pruijt HF; Novotny VM; Vreugdenhil A; de Groot MR; de Weerdt O; van Pampus EC; van Maanen-Lamme TM; Wittebol S; Schipperus MR; Silbermann MH; Huijgens PC; Luten M; Hollestein R; Brakenhoff JA; Schrama JG; Valster FA; Velders GA; Koene HR;
    Haematologica; 2015 Mar; 100(3):e90-2. PubMed ID: 25425692
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of refractory immune thrombocytopenia with rituximab in a 10-week-old infant.
    Gray C; Kalumba K; Pati N; Peterson A; Connell TG
    J Pediatr Hematol Oncol; 2013 May; 35(4):e174-7. PubMed ID: 23459375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell depletion in immune thrombocytopenia.
    Psaila B; Cooper N
    Lancet; 2015 Apr; 385(9978):1599-601. PubMed ID: 25662418
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab for adult primary immune thrombocytopenia.
    Frederiksen H
    Lancet Haematol; 2015 Feb; 2(2):e52-3. PubMed ID: 26687609
    [No Abstract]   [Full Text] [Related]  

  • 7. Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia.
    Arnold DM; Crowther MA; Meyer RM; Carruthers J; Ditomasso J; Heddle NM; McLeod A; Kelton JG
    Transfusion; 2010 Dec; 50(12):2577-81. PubMed ID: 20576011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia.
    Audia S; Samson M; Mahévas M; Ferrand C; Trad M; Ciudad M; Gautheron A; Seaphanh F; Leguy V; Berthier S; Salles B; Martin L; Lorcerie B; Ortega-Deballon P; Facy O; Caillot D; Soudry-Faure A; Michel M; Godeau B; Larmonier N; Saas P; Janikashvili N; Bonnotte B
    Blood; 2013 Oct; 122(14):2477-86. PubMed ID: 23963041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children.
    Roganovic J
    Eur J Pediatr; 2005 May; 164(5):334. PubMed ID: 15711954
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab for the treatment of acute refractory ITP.
    Kim SG; Whyte D; Pashankar FD
    J Pediatr Hematol Oncol; 2014 Apr; 36(3):e149-51. PubMed ID: 23669737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of rituximab in chronic childhood immune thrombocytopenic purpura.
    Bay A; Oner AF; Uner A; Dogan M
    Pediatr Int; 2006 Oct; 48(5):514-6. PubMed ID: 16970796
    [No Abstract]   [Full Text] [Related]  

  • 12. [Commentary on "Rituximab in thrombocytopenic purpura..."].
    García-Álvarez JL
    Rev Med Inst Mex Seguro Soc; 2012; 50(4):351-2. PubMed ID: 23234734
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple cycles of rituximab therapy in chronic refractory immune thrombocytopenia: a case report with a 10-year follow-up.
    Routy B; Boulassel MR; Spurll GM; Warner MN; Routy JP
    Am J Ther; 2013; 20(2):219-22. PubMed ID: 23466621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reply to commentary on "Rituximab in thrombocytopenic purpura..."].
    Zambrano-Velarde MA; de la O-Peña D; Chávez-Peña Q; Bedolla-Barajas M
    Rev Med Inst Mex Seguro Soc; 2012; 50(4):353-4. PubMed ID: 23234735
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recurrent infections in an ITP patient treated with rituximab].
    Rosenberg-Bezalel S; Asher I; Sthoeger Z
    Harefuah; 2012 Nov; 151(11):617-9, 655. PubMed ID: 23367730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.
    Audia S; Samson M; Guy J; Janikashvili N; Fraszczak J; Trad M; Ciudad M; Leguy V; Berthier S; Petrella T; Aho-Glélé S; Martin L; Maynadié M; Lorcerie B; Rat P; Cheynel N; Katsanis E; Larmonier N; Bonnotte B
    Blood; 2011 Oct; 118(16):4394-400. PubMed ID: 21876120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment results of children with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.
    Citak EC; Citak FE
    J Trop Pediatr; 2011 Feb; 57(1):71-2. PubMed ID: 20463085
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
    Wang W; Yu QH; Zhang HY; Chu XX; Chen F; Zhang CQ; Zhou YH; Hou M
    Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy.
    Shores D; Kobak G; Pegram LD; Whitington PF; Shneider BL
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):e128-30. PubMed ID: 21921813
    [No Abstract]   [Full Text] [Related]  

  • 20. [Persistent hypogammaglobulinemia in an ITP patient following treatment with rituximab].
    Toubi E
    Harefuah; 2012 Nov; 151(11):620-1, 655. PubMed ID: 23367731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.